Vol. 24 No. 1 (2020)
CASE REPORTS

Transseptal transcatheter valve-in-valve implantation for failed surgical mitral bioprosthesis: the first clinical experience

V. Ganyukov
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo
E. Shloido
City Multidisciplinary Hospital No. 2, Saint Petersburg
R. Tarasov
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo
N. Rogulina
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo
Bio
I. Khalivopulo
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo
I. Ganyukov
Kemerovo Cardiology Dispensary, Kuzbass Cardiology Center, Kemerovo
A. Kochergina
Kemerovo State Medical University, Kemerovo
I. Sizova
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo
L. Barbarash
Research Institute for Complex Issues of Cardiovascular Diseases, Kuzbass Cardiology Center, Kemerovo

Published 2020-04-07

Keywords

  • bioprosthesis dysfunction,
  • clinical case,
  • transcatheter implantation,
  • transcatheter mitral valve-in-valve,
  • valve-in-valve

How to Cite

Ganyukov, V., Shloido, E., Tarasov, R., Rogulina, N., Khalivopulo, I., Ganyukov, I., Kochergina, A., Sizova, I., & Barbarash, L. (2020). Transseptal transcatheter valve-in-valve implantation for failed surgical mitral bioprosthesis: the first clinical experience. Patologiya Krovoobrashcheniya I Kardiokhirurgiya, 24(1), 94–103. https://doi.org/10.21688/1681-3472-2020-1-94-103

Abstract

A clinical case of endovascular correction of a biological mitral valve prosthesis dysfunction by implantation of a transcatheter aortic valve into the mitral position is described. Considering the clinical status of the patient, the condition was determined to be inoperable. Subsequently, based on vital fluoroscopy and echocardiography findings, the patient was implanted with a transcatheter aortic valve in the mitral valve bioprosthesis position. The technical and clinical aspects of the intervention and its results were analysed during the hospital period and for 5 months after implantation. The selected method of treatment was found to be appropriate.

Received 10 January 2020. Revised 18 March 2020. Accepted 19 March 2020.

Funding: The study did not have sponsorship.

Conflict of interest: Authors declare no conflict of interest.

Author contributions
Drafting the article: N.V. Rogulina, I.V. Ganyukov, A.M. Kochergina, V.I. Ganyukov, R.S. Tarasov, I.K. Khalivopulo, I.N. Sizova
Literature review: V.I. Ganyukov, R.S. Tarasov, N.V. Rogulina, I.K. Khalivopulo, I.V. Ganyukov, A.M. Kochergina
Illustrations: I.V. Ganyukov, I.N. Sizova, N.V. Rogulina
Critical revision of the article: V.I. Ganyukov, R.S. Tarasov, E.A. Shloido, L.S. Barbarash
Surgical treatment: E.A. Shloido, V.I. Ganyukov, R.S. Tarasov
Final approval of the version to be published: V.I. Ganyukov, E.A. Shloido, R.S. Tarasov, N.V. Rogulina, I.K. Khalivopulo, I.V. Ganyukov, A.M. Kochergina, I.N. Sizova, L.S. Barbarash

References

  1. Yoon S.-H., Whisenant B.K., Bleiziffer S., Delgado V., Dhoble A., Schofer N., Eschenbach L., Bansal E., Murdoch D.J., Ancona M., Schmidt T., Yzeiraj E., Vincent F., Niikura H., Kim W.K., Asami M., Unbehaun A., Hirji S., Fujita B., Silaschi M., Tang G.H.L., Kuwata S., Wong S.C., Frangieh A.H., Barker C.M., Davies J.E., Lauten A., Deuschl F., Nombela-Franco L., Rampat R., Nicz P.F.G., Masson J.B., Wijeysundera H.C., Sievert H., Blackman D.J., Gutierrez-Ibanes E., Sugiyama D., Chakravarty T., Hildick-Smith D., de Brito F.S. Jr., Jensen C., Jung C., Smalling R.W., Arnold M., Redwood S., Kasel A.M., Maisano F., Treede H., Ensminger S.M., Kar S., Kaneko T., Pilgrim T., Sorajja P., Van Belle E., Prendergast B.D., Bapat V., Modine T., Schofer J., Frerker C., Kempfert J., Attizzani G.F., Latib A., Schaefer U., Webb J.G., Bax J.J., Makkar R.R. Outcomes of transcathetermitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40(5):441-51. PMID: 30357365. https://doi.org/10.1093/eurheartj/ehy590
  2. Lloyd G.W., Joseph T.A., Cabalka A.K., Guerrero M., Rihal C.S., Eleid M.F. Hemodynamic and clinical response to transseptal mitral valve-in-valve and valve-in-ring. Catheter Cardiovasc Interv. 2019;94(3):458-66. PMID: 30790436. https://doi.org/10.1002/ccd.28149
  3. Горбунова Е.В., Пенская Т.Ю., Рогулина Н.В., Максимов С.А., Салахов Р.Р., Журавлева И.Ю., Барбараш О.Л. Влияние обучающей программы на эффективность и безопасность антикоагулянтной терапии у пациентов с протезированными клапанами сердца. Кардиология. 2013;53(8):67-71. [Gorbunova E.V., Penskaya T.Yu., Rogulina N.V., Maximov S.A., Salakhov R.R., Zhuravleva I.Yu., Barbarash O.L. Effect of an educational program on effectiveness and safety of anticoagulant therapy in patients with prostheses of cardiac valves. Kardiologia. 2013;53(8):67-71. (In Russ.)] https://www.elibrary.ru/download/elibrary_20468780_20424325.pdf
  4. Абдуллаев Ф.3., Аббасов Ф.Э., Гейбатов И.Д., Багиров И.М., Гушанов Ш.А., Рустамов В.Н., Шихиева Л.С., Махмудов И.С. Предикторы риска и современные принципы коррекции разрывов задней стенки левого желудочка после протезирования митрального клапана (обзор литературы и собственное наблюдение). Грудная и сердечно-сосудистая хирургия. 2011;2:23-29. [Abdullaev F.Z., Abbasov F.E., Geybatov I.D., Bagirov I.M., Gushanov Sh.A., Rustamov V.N., Shikhieva L.S., Makhmudov I.S. Predictors of risk and modern principles of correction of the left ventricular posterior wall ruptures after mitral valve replacement (literature review and personal observation). Russian Journal of Thoracic and Cardiovascular Surgery. 2011;2:23-29. (In Russ.)] https://www.elibrary.ru/download/elibrary_21275958_34099557.pdf
  5. Рогулина Н.В., Халивопуло И.К. “Valve-On-Valve” — альтернативная методика хирургического лечения дисфункций биологических протезов клапанов сердца. Российский кардиологический журнал. 2019;8:140-149. [Rogulina N.V., Khalivopulo I.K. “Valve-On-Valve” — an alternative method of surgical treatment of tissue valve dysfunctions. Russian Journal of Cardiology. 2019;8:140-149. (In Russ.)] https://doi.org/10.15829/1560-4071-2019-8-140-149
  6. Mirabel M., Iung B., Baron G., Messika-Zeitoun D., Détaint D., Vanoverschelde J.L., Butchart E.G., Ravaud P., Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28(11):1358-65. PMID: 17350971. https://doi.org/10.1093/eurheartj/ehm001
  7. Kamioka N., Babaliaros V., Morse M.A., Frisoli T., Lerakis S., Iturbe J.M., Binongo J., Corrigan F., Yousef A., Gleason P., Wells J.A. 4th, Caughron H., Dong A., Rodriguez E., Leshnower B., O’Neill W., Paone G., Eng M., Guyton R., Block P.C., Greenbaum A. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. J Am Coll Cardiol Intv. 2018;11(12):1131-8. PMID: 29929633. https://doi.org/10.1016/j.jcin.2018.03.011
  8. El Hajj S.C., Eleid M.F. Transcatheter mitral valve replacement: an update on the current literature. Curr Treat Options Cardiovasc Med. 2019;21(7):35. PMID: 31209590. https://doi.org/10.1007/s11936-019-0734-3
  9. Regueiro A., Granada J.F., Dagenais F., Rodés-Cabau J. Transcatheter mitral valve replacement: insights from early clinical experience and future challenges. J Am Coll Cardiol. 2017;69(17):2175-92. PMID: 28449780. https://doi.org/10.1016/j.jacc.2017.02.045
  10. Naksuk N., Asirvatham S.J. Iatrogenic atrial septal defect: reassurance or inquisitiveness. J Interv Card Electrophysiol. 2018;52(2):137-40. https://doi.org/10.1007/s10840-018-0369-4